Neurosense Therapeuti -CW23NRSNWPreferred / convertible
13F holders, Q4 2024 (December 31)4holders
0new positions
0sold out
1famous investor
$0.41avg. 13F price*
At the end of Q4 2024, 4 institutions reported holding Neurosense Therapeuti -CW23 (NRSNW) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were Clear Street LLC ($29K), Warberg Asset Management LLC ($8K) and Citadel Advisors ($7K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Neurosense Therapeuti -CW23
- CUSIP
- M74240116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 5,034 shares sold, net −5,034 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Clear Street LLC | — | Reduce -0.1% | 65,659 | $29K |
| Warberg Asset Management LLC | — | Reduce -11.2% | 17,936 | $8K |
| Citadel Advisors | — | Reduce -10.1% | 22,711 | $7K |
| UBS Group AG | — | Reduce -53.0% | 94 | $41 |
"% of holder's portfolio" is NRSNW's weight in each manager's 13F, not the share of Neurosense Therapeuti -CW23 the manager owns.